Abstract
1-Amino-3-{2-[7-(6-deoxy-α/β-D-galactopyranos- 6-yl)-1,7-dicarba-closo-dodecaboran(12)-1-yl]ethyl}cyclobutanecarboxylic acid was synthesized as a potential new agent for boron neutron capture therapy. The key step in the synthesis is the alkylation of 3-{2-[1,7-dicarba-closo-dodecaboran(12)-1-yl]ethyl}cyclobutanone ethylene monothioketal with 1,2:3,4-di-O-isopropylidene-6-O-triflyl-α-D-galactopyranose which gave the precursor ketone that was then converted to the title amino acid via a Bücherer-Strecker synthesis followed by removal of isopropylidene groups in HCl. Preliminary toxicity data in A 435 cancer cells were obtained.
| Original language | English |
|---|---|
| Pages (from-to) | 836-842 |
| Number of pages | 7 |
| Journal | Collection of Czechoslovak Chemical Communications |
| Volume | 67 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2002 |
Keywords
- Amino acids
- BNCT
- Boron neutron capture therapy
- Carbohydrates
- Carboranes
Fingerprint
Dive into the research topics of 'Synthesis of 1-amino-3-{2-[7-(6-deoxy-α/β-D-galactopyranos-6-YL) -1,7-dicarba-closo-dodecaboran(12)-1-YL]ethyl}cyclobutanecarboxylic acid hydrochloride'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver